# Low Dose IL-2 for Ulcerative Colitis

> **NCT02200445** · PHASE1 · COMPLETED · sponsor: **Scott B. Snapper, MD PHD** · enrollment: 26 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Interleukin-2 (aldesleukin).

## Key facts

- **NCT ID:** NCT02200445
- **Lead sponsor:** Scott B. Snapper, MD PHD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2020-10-01
- **Final completion:** 2021-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02200445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02200445, "Low Dose IL-2 for Ulcerative Colitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02200445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*